Literature DB >> 17523701

Aspirin and Reye syndrome.

Dominic A Fitzgerald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17523701     DOI： 10.2165/00148581-200709030-00009

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  10 in total

Review 1.  Reye syndrome--insights on causation and prognosis.

Authors:  J F Glasgow; B Middleton
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

2.  Reye's syndrome in the United States from 1981 through 1997.

Authors:  E D Belay; J S Bresee; R C Holman; A S Khan; A Shahriari; L B Schonberger
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

3.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD.

Authors:  R D REYE; G MORGAN; J BARAL
Journal:  Lancet       Date:  1963-10-12       Impact factor: 79.321

Review 4.  Reye's syndrome: current concepts.

Authors:  J E Heubi; J C Partin; J S Partin; W K Schubert
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

5.  Reye syndrome in Ohio, 1973-1977.

Authors:  J Z Sullivan-Bolyai; J S Marks; D Johnson; D B Nelson; F Holtzhauer; F Bright; T Kramer; T J Halpin
Journal:  Am J Epidemiol       Date:  1980-11       Impact factor: 4.897

6.  Whatever happened to Reye's syndrome? Did it ever really exist?

Authors:  J P Orlowski
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

7.  Reye's syndrome. A reappraisal of diagnosis in 49 presumptive cases.

Authors:  M Gauthier; J Guay; J Lacroix; A Lortie
Journal:  Am J Dis Child       Date:  1989-10

8.  The changing clinical pattern of Reye's syndrome 1982-1990.

Authors:  R M Hardie; L H Newton; J C Bruce; J F Glasgow; A P Mowat; J B Stephenson; S M Hall
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

9.  Reye's syndrome and salicylate use, by Karen M. Starko, MD, et al, Pediatrics, 1980;66:859-864; and National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985, by Janet B. Arrowsmith et al, Pediatrics, 1987;79:858-863.

Authors:  R E Kauffman
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

10.  Aspirin and Reye's syndrome. How strong an association?

Authors:  J P Orlowski
Journal:  Postgrad Med       Date:  1984-05       Impact factor: 3.840
  10 in total
  3 in total

1.  Fever: to treat or not to treat?

Authors:  Miguel Glatstein; Dennis Scolnik
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

Review 2.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

Review 3.  Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

Authors:  Alessandra Marchesi; Donato Rigante; Rolando Cimaz; Angelo Ravelli; Isabella Tarissi de Jacobis; Alessandro Rimini; Fabio Cardinale; Marco Cattalini; Andrea De Zorzi; Rosa Maria Dellepiane; Patrizia Salice; Aurelio Secinaro; Andrea Taddio; Paolo Palma; Maya El Hachem; Elisabetta Cortis; Maria Cristina Maggio; Giovanni Corsello; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.